Replies to post #2097 on Rexahn Pharmaceuticals, Inc. (REXN)

[pink floyd]

Thanks for the reply. The world of small biotech is quite the jungle. Finding the diamond amidst all of it is the challenge. I have found some of the best and safest ways to make money is to sell right after a successful phase two trial is announced. Then, keep an eye on the phase three trial and reinvest accordingly. RNN is a long termer for me because a phase two result on Archexin is a ways off and phase two for the other two compounds is even farther.
However, phase one trial results later this year and a partnership would be great catalysts for this stock. If Archexin does well and the other two compounds have successful phase two trials this stock could be in double digits in 2015.